AU2003280285A8 - Gucy1b2 genetic markers for ldl cholesterol response to statin therapy - Google Patents

Gucy1b2 genetic markers for ldl cholesterol response to statin therapy

Info

Publication number
AU2003280285A8
AU2003280285A8 AU2003280285A AU2003280285A AU2003280285A8 AU 2003280285 A8 AU2003280285 A8 AU 2003280285A8 AU 2003280285 A AU2003280285 A AU 2003280285A AU 2003280285 A AU2003280285 A AU 2003280285A AU 2003280285 A8 AU2003280285 A8 AU 2003280285A8
Authority
AU
Australia
Prior art keywords
gucy1b2
genetic markers
ldl cholesterol
statin therapy
cholesterol response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003280285A
Other versions
AU2003280285A1 (en
Inventor
Carol R Reed
Bradley J Dain
Ping Zhan
Chad Messer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Publication of AU2003280285A1 publication Critical patent/AU2003280285A1/en
Publication of AU2003280285A8 publication Critical patent/AU2003280285A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
AU2003280285A 2002-06-28 2003-06-30 Gucy1b2 genetic markers for ldl cholesterol response to statin therapy Abandoned AU2003280285A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39281802P 2002-06-28 2002-06-28
US60/392,818 2002-06-28
PCT/US2003/020606 WO2004003167A2 (en) 2002-06-28 2003-06-30 Gucy1b2 genetic markers for ldl cholesterol response to statin therapy

Publications (2)

Publication Number Publication Date
AU2003280285A1 AU2003280285A1 (en) 2004-01-19
AU2003280285A8 true AU2003280285A8 (en) 2004-01-19

Family

ID=30000940

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003280285A Abandoned AU2003280285A1 (en) 2002-06-28 2003-06-30 Gucy1b2 genetic markers for ldl cholesterol response to statin therapy

Country Status (2)

Country Link
AU (1) AU2003280285A1 (en)
WO (1) WO2004003167A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1784504A2 (en) * 2004-07-21 2007-05-16 Institut National De La Sante Et De La Recherche Medicale (Inserm) Oatp-c gene c463a polymorphism underlies variable response of statin therapy

Also Published As

Publication number Publication date
AU2003280285A1 (en) 2004-01-19
WO2004003167A2 (en) 2004-01-08
WO2004003167A3 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
AU2003294828A1 (en) Specific markers for pancreatic cancer
AU2003205950A1 (en) Placement of alternative advertisements
EP1526865A4 (en) Compounds for targeting hepatocytes
AUPS329602A0 (en) Fertilisation of soil
AU2003299100A1 (en) Pyrimidine compounds as therapeutic agents
EP1646834A1 (en) Condensor
AU2003235859A1 (en) Exercise support system
AU2003215150A1 (en) Therapeutic compounds
EP1494679A4 (en) Step-down estrogen therapy
GB0225360D0 (en) Genetic markers
AU2003297657A1 (en) Antifungal therapeutic agents
AUPS213802A0 (en) Disaccharides for drug discovery
AU2003280285A8 (en) Gucy1b2 genetic markers for ldl cholesterol response to statin therapy
AU2003284111A1 (en) Itgb3 gene haplotypes and atorvastatin dose effects on hdl cholesterol
AU2003240559A1 (en) Modular protective structure for floor display
AU2003205100A1 (en) Novel cholesterol absorption lowering agents
AU2003257434A1 (en) L-amidase from rhizobium huautlense
AU2003254043A1 (en) Antifungal therapeutic targets
AU2003286280A1 (en) Grave-constructions for above ground multiple burials
AU2003231937A1 (en) Therapeutic methods
AU2003293581A1 (en) Method of identifying therapeutic agents
AU2003272459A8 (en) Distillation system
AUPR501001A0 (en) Genome-wide transcriptional analysis for identifying genetic markers
GB0228704D0 (en) Novel therapeutic target
AU2003244402A1 (en) Genetic markers for bone mass

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase